Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Dubovsky

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|December 19, 2018
Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorderSteven L Dubovsky
Psychotherapy and Psychosomatics|May 23, 2018
What Is New about New Antidepressants?Steven L Dubovsky
Journal of Clinical Psychopharmacology|February 21, 2022
Calcium Channel Antagonists for Mood DisordersSteven L Dubovsky, Dori Marshall
Expert Opinion on Pharmacotherapy|October 12, 2017
Pharmacotherapy of mood disorders and psychosis in pre- and post-natal womenBeth Smith, Steven L Dubovsky
Expert Opinion on Investigational Drugs|September 18, 2009
Agomelatine, a melatonin agonist with antidepressant propertiesSteven L Dubovsky, Calvert Warren
Psychotherapy and Psychosomatics|May 3, 2022
Benzodiazepines Remain Important Therapeutic Options in Psychiatric PracticeSteven L Dubovsky, Dori Marshall
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 29, 2021
We Should Continue to Be Concerned About Conflicts of Interest in Academic MedicineSteven L Dubovsky, Richard Balon
Neuropsychiatric Disease and Treatment|June 21, 2013
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of maniaCalvert G Warren, Steven L Dubovsky
Seminars in Neurology|June 25, 2009
Psychopharmacology for neurologistsSteven L Dubovsky, Amelia N Dubovsky
Expert Opinion on Pharmacotherapy|March 10, 2011
Ziprasidone for maintenance treatment of bipolar I disorder in adultsSteven L Dubovsky, Amelia N Dubovsky
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Metabolism & Toxicology|December 19, 2018
Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorderSteven L Dubovsky
Psychotherapy and Psychosomatics|May 23, 2018
What Is New about New Antidepressants?Steven L Dubovsky
Journal of Clinical Psychopharmacology|February 21, 2022
Calcium Channel Antagonists for Mood DisordersSteven L Dubovsky, Dori Marshall
Expert Opinion on Pharmacotherapy|October 12, 2017
Pharmacotherapy of mood disorders and psychosis in pre- and post-natal womenBeth Smith, Steven L Dubovsky
Expert Opinion on Investigational Drugs|September 18, 2009
Agomelatine, a melatonin agonist with antidepressant propertiesSteven L Dubovsky, Calvert Warren
Psychotherapy and Psychosomatics|May 3, 2022
Benzodiazepines Remain Important Therapeutic Options in Psychiatric PracticeSteven L Dubovsky, Dori Marshall
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|January 29, 2021
We Should Continue to Be Concerned About Conflicts of Interest in Academic MedicineSteven L Dubovsky, Richard Balon
Neuropsychiatric Disease and Treatment|June 21, 2013
New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of maniaCalvert G Warren, Steven L Dubovsky
Seminars in Neurology|June 25, 2009
Psychopharmacology for neurologistsSteven L Dubovsky, Amelia N Dubovsky
Expert Opinion on Pharmacotherapy|March 10, 2011
Ziprasidone for maintenance treatment of bipolar I disorder in adultsSteven L Dubovsky, Amelia N Dubovsky
Pageof 5